The Neuroendocrine Cancer Foundation Podcast - Top 10 FAQs with neuroendocrine cancer experts

Episode 25: What to Know about Grade 3 Poorly Differentiated Neuroendocrine Carcinoma (NEC)

Learn Advocate Connect Neuroendocrine Tumor Society Season 1 Episode 25

What are Grade 3 Poorly Differentiated Neuroendocrine Carcinoma (NEC)? What makes NEC unique? Can a NET transform to NEC? Dr Nitja Raj from Memorial Sloan Kettering Cancer Center in New York City explains NEC tumor biology and how it guides treatment strategy. She also discusses current clinical trials and research.

For more information, visit LACNETS.org/podcast/24. 

For more information, visit LACNETS.org.